BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18338615)

  • 1. [Study on preparation of phenols gastric floating tablet].
    Zhai XL; Ni J; Gu YL
    Zhongguo Zhong Yao Za Zhi; 2008 Jan; 33(1):31-4. PubMed ID: 18338615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric floating matrix tablets: design and optimization using combination of polymers.
    Prajapati ST; Patel LD; Patel DM
    Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Floating matrix dosage form for dextromethorphan hydrobromide based on gas forming technique: in vitro and in vivo evaluation in healthy volunteers.
    Hu L; Li L; Yang X; Liu W; Yang J; Jia Y; Shang C; Xu H
    Eur J Pharm Sci; 2011 Jan; 42(1-2):99-105. PubMed ID: 21050887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of 3D printing technologies and compressed tablets for preparation of riboflavin floating tablet-in-device (TiD) systems.
    Fu J; Yin H; Yu X; Xie C; Jiang H; Jin Y; Sheng F
    Int J Pharm; 2018 Oct; 549(1-2):370-379. PubMed ID: 30107218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compressibility of gastroretentive pellets coated with Eudragit NE using a single-stroke and a rotary tablet press.
    Łunio R; Sawicki W; Skoczeń P; Walentynowicz O; Kubasik-Juraniec J
    Pharm Dev Technol; 2008; 13(4):323-31. PubMed ID: 18649222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eudragit E as excipient for production of granules and tablets from Phyllanthus niruri L spray-dried extract.
    Pereira de Souza T; Martínez-Pacheco R; Gómez-Amoza JL; Petrovick PR
    AAPS PharmSciTech; 2007 Apr; 8(2):Article 34. PubMed ID: 17622112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation.
    Sauzet C; Claeys-Bruno M; Nicolas M; Kister J; Piccerelle P; Prinderre P
    Int J Pharm; 2009 Aug; 378(1-2):23-9. PubMed ID: 19465095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.
    Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of verapamil hydrochloride core-in-cup tablets with double-pulsatile and multi-phasic release].
    Li CJ; Zhu JB; Yu WY
    Yao Xue Xue Bao; 2008 Jun; 43(6):652-6. PubMed ID: 18822971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tableting of floating pellets with verapamil hydrochloride: influence of type of tablet press.
    Sawicki W; Łunio R
    Acta Pol Pharm; 2010; 67(1):103-6. PubMed ID: 20210087
    [No Abstract]   [Full Text] [Related]  

  • 12. Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
    Aryal S; Skalko-Basnet N
    Acta Pharm; 2008 Sep; 58(3):299-308. PubMed ID: 19103566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroretentive drug delivery system of DA-6034, a new flavonoid derivative, for the treatment of gastritis.
    Jang SW; Lee JW; Park SH; Kim JH; Yoo M; Na DH; Lee KC
    Int J Pharm; 2008 May; 356(1-2):88-94. PubMed ID: 18276090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon specific CODES based Piroxicam tablet for colon targeting: statistical optimization, in vivo roentgenography and stability assessment.
    Singh AK; Pathak K
    Pharm Dev Technol; 2015 Mar; 20(2):237-45. PubMed ID: 24266719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of powder characteristics on oral tablet disintegration.
    Yamamoto Y; Fujii M; Watanabe K; Tsukamoto M; Shibata Y; Kondoh M; Watanabe Y
    Int J Pharm; 2009 Jan; 365(1-2):116-20. PubMed ID: 18804156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
    Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
    Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, development and optimization of a novel time and pH-dependent colon targeted drug delivery system.
    Patel MM; Shah TJ; Amin AF; Shah NN
    Pharm Dev Technol; 2009; 14(1):62-9. PubMed ID: 18802844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Starch/microcrystalline cellulose hybrid gels as gastric-floating drug delivery systems.
    Xu J; Tan X; Chen L; Li X; Xie F
    Carbohydr Polym; 2019 Jul; 215():151-159. PubMed ID: 30981340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hollow microspheres of diclofenac sodium - a gastroretentive controlled delivery system.
    Bv B; R D; S B; Abraham S; Furtado S; V M
    Pak J Pharm Sci; 2008 Oct; 21(4):451-4. PubMed ID: 18930869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.